Skip to content

Olympus Aspartate Aminotransferase Reagent

by Olympus Corp. 510(k) 2 variants

Active United States

510(k) K925155

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK925155 Date26 Jan 1993ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CIT
Device Class
Class II
Regulation
21 CFR Part 862.1100
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Olympus Aspartate Aminotransferase Reagent is a clinical chemistry reagent used for the measurement of aspartate aminotransferase (AST/SGOT) through NADH oxidation/NAD reduction method. It is classified under product code CIT for clinical chemistry applications.

This reagent is supplied by Olympus Corp. and is intended for laboratory use. It is a Class II device cleared by the FDA under 510(k) K925155 and K922885, with clearance dates of January 26, 1993, and July 28, 1992, respectively. The device is not specified as single-use or reusable, and no information regarding sterility, MRI safety, or storage conditions is provided in the data.

Other devices from Olympus Corp.

See all devices from Olympus Corp. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Olympus Aspartate Aminotransferase Reagent used for?

    The Olympus Aspartate Aminotransferase Reagent is used for the measurement of aspartate aminotransferase (AST/SGOT) through the NADH oxidation/NAD reduction method in clinical chemistry applications.

  • How is the Olympus Aspartate Aminotransferase Reagent supplied and intended for use?

    The reagent is supplied by Olympus Corp. and is intended for laboratory use in clinical chemistry testing to measure AST/SGOT levels.

  • What regulatory pathway was used for the Olympus Aspartate Aminotransferase Reagent?

    The device was cleared by the FDA through the 510(k) pathway, with substantial equivalence demonstrated under K925155 (cleared January 26, 1993) and K922885 (cleared July 28, 1992).